Benin vs Ecuador: HIV/AIDS deaths averted by antiretroviral therapy
Benin
3,910 deaths
in 2024
Ecuador
3,034 deaths
in 2024
Benin rank
47th
Ecuador rank
49th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Benin
- Ecuador
How they compare
Benin currently reports 3,910 deaths against 3,034 deaths in Ecuador, a difference of 876 deaths.
That makes Benin's figure about 1.3 times Ecuador's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Ecuador ahead.
Benin ranks 47th and Ecuador ranks 49th of 157 countries.
Across the 4 decades both report, Benin averaged higher in 3 and Ecuador in 1.
Head to head by decade
| Decade | Benin | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 26.07 deaths | 26.07 deaths | Ecuador |
| 2000s | 514.49 deaths | 314.14 deaths | 200.35 deaths | Benin |
| 2010s | 3,602 deaths | 1,733 deaths | 1,869 deaths | Benin |
| 2020s | 3,905 deaths | 2,906 deaths | 998.61 deaths | Benin |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Benin or Ecuador?
- Benin, at 3,910 deaths against 3,034 deaths in Ecuador as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Benin and Ecuador?
- 876 deaths, with Benin ahead.
- How many years of comparable data are there for Benin and Ecuador?
- 35 years are reported by both, from 1990 to 2024.
- How do Benin and Ecuador rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Benin ranks 47th and Ecuador ranks 49th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.